(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of KYNU mRNA] CTD PMID:31150632 (-)-demecolcine increases expression ISO KYNU (Homo sapiens) 6480464 Demecolcine results in increased expression of KYNU mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions ISO Kynu (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of KYNU mRNA CTD PMID:36331819 1,2-dimethylhydrazine increases expression ISO Kynu (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of KYNU mRNA CTD PMID:22206623 1-benzylpiperazine decreases expression EXP 6480464 N-benzylpiperazine results in decreased expression of KYNU mRNA CTD PMID:26821219 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of KYNU mRNA CTD PMID:25380136 and PMID:30723492 17beta-estradiol multiple interactions ISO KYNU (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of KYNU mRNA CTD PMID:20660070 17beta-estradiol decreases expression ISO KYNU (Homo sapiens) 6480464 Estradiol results in decreased expression of KYNU mRNA CTD PMID:21185374 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Kynu (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of KYNU mRNA CTD PMID:18796159 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KYNU mRNA CTD PMID:19692669 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of KYNU mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Kynu (Mus musculus) 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of KYNU mRNA CTD PMID:16214954 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of KYNU mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:19692669 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of KYNU protein CTD PMID:34915118 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of KYNU mRNA CTD PMID:25380136 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of KYNU mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO Kynu (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of KYNU mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO KYNU (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of KYNU gene CTD PMID:27153756 aflatoxin B1 increases expression ISO KYNU (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of KYNU mRNA CTD PMID:27153756 aldehydo-D-glucose multiple interactions ISO Kynu (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KYNU mRNA CTD PMID:37567420 all-trans-retinoic acid increases expression ISO KYNU (Homo sapiens) 6480464 Tretinoin results in increased expression of KYNU mRNA CTD PMID:16249480 and PMID:33167477 antirheumatic drug decreases expression ISO KYNU (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of KYNU mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO KYNU (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of KYNU mRNA CTD PMID:33212167 arsenous acid increases expression ISO KYNU (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of KYNU mRNA CTD PMID:15761015 atazanavir sulfate multiple interactions ISO KYNU (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of KYNU mRNA CTD PMID:33819548 azathioprine increases expression ISO KYNU (Homo sapiens) 6480464 Azathioprine results in increased expression of KYNU mRNA CTD PMID:22623647 benzo[a]pyrene increases expression ISO KYNU (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of KYNU mRNA CTD PMID:21632981 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of KYNU mRNA CTD PMID:18164116 beta-naphthoflavone increases expression ISO KYNU (Homo sapiens) 6480464 beta-Naphthoflavone results in increased expression of KYNU mRNA CTD PMID:19737606 bis(2-chloroethyl) sulfide increases expression ISO KYNU (Homo sapiens) 6480464 Mustard Gas results in increased expression of KYNU mRNA CTD PMID:25102026 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KYNU mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KYNU mRNA CTD PMID:32145629 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of KYNU mRNA CTD PMID:30903817 bisphenol A affects expression ISO KYNU (Homo sapiens) 6480464 bisphenol A affects the expression of KYNU mRNA CTD PMID:30903817 bisphenol A increases expression ISO KYNU (Homo sapiens) 6480464 bisphenol A results in increased expression of KYNU mRNA CTD PMID:29275510 bisphenol A decreases expression ISO KYNU (Homo sapiens) 6480464 bisphenol A results in decreased expression of KYNU mRNA CTD PMID:28711546 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of KYNU gene CTD PMID:28505145 buta-1,3-diene decreases expression ISO Kynu (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of KYNU mRNA CTD PMID:29038090 cadmium atom increases expression ISO KYNU (Homo sapiens) 6480464 Cadmium results in increased expression of KYNU mRNA CTD PMID:21172416 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of KYNU mRNA CTD PMID:25993096 cantharidin increases expression ISO Kynu (Mus musculus) 6480464 Cantharidin results in increased expression of KYNU mRNA CTD PMID:36907384 carbon nanotube decreases expression ISO Kynu (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of KYNU mRNA CTD PMID:25620056 carbon nanotube increases expression ISO Kynu (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 chenodeoxycholic acid multiple interactions ISO KYNU (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of KYNU mRNA more ... CTD PMID:33819548 chloropicrin increases expression ISO KYNU (Homo sapiens) 6480464 chloropicrin results in increased expression of KYNU mRNA CTD PMID:26352163 cisplatin decreases expression ISO KYNU (Homo sapiens) 6480464 Cisplatin results in decreased expression of KYNU mRNA CTD PMID:27392435 clomiphene increases expression ISO KYNU (Homo sapiens) 6480464 Clomiphene results in increased expression of KYNU mRNA CTD PMID:26865669 cobalt dichloride decreases expression ISO KYNU (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of KYNU mRNA CTD PMID:19376846 copper atom decreases expression EXP 6480464 Copper results in decreased expression of KYNU mRNA CTD PMID:22465980 copper atom multiple interactions ISO KYNU (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of KYNU mRNA CTD PMID:20971185 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of KYNU mRNA CTD PMID:22465980 copper(0) multiple interactions ISO KYNU (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of KYNU mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO KYNU (Homo sapiens) 6480464 Copper Sulfate results in increased expression of KYNU mRNA CTD PMID:19549813 coumarin decreases expression EXP 6480464 coumarin results in decreased expression of KYNU mRNA CTD PMID:18480146 crocidolite asbestos increases expression ISO KYNU (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of KYNU mRNA CTD PMID:24160326 and PMID:25351596 crocidolite asbestos decreases expression ISO Kynu (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of KYNU mRNA CTD PMID:29279043 crocidolite asbestos affects expression ISO KYNU (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of KYNU mRNA CTD PMID:25757056 curcumin increases expression ISO KYNU (Homo sapiens) 6480464 Curcumin results in increased expression of KYNU mRNA CTD PMID:18421014 cyanocob(III)alamin multiple interactions EXP 6480464 [Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Rotenone results in decreased expression of KYNU mRNA] CTD PMID:36553663 cyclosporin A decreases expression ISO Kynu (Mus musculus) 6480464 Cyclosporine results in decreased expression of KYNU mRNA CTD PMID:19770486 cyclosporin A multiple interactions ISO KYNU (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of KYNU mRNA CTD PMID:33819548 cyclosporin A increases expression ISO KYNU (Homo sapiens) 6480464 Cyclosporine results in increased expression of KYNU mRNA CTD PMID:20106945 and PMID:25562108 cypermethrin decreases activity ISO Kynu (Mus musculus) 6480464 cypermethrin results in decreased activity of KYNU protein CTD PMID:7175100 cytarabine decreases expression ISO KYNU (Homo sapiens) 6480464 Cytarabine results in decreased expression of KYNU mRNA CTD PMID:21198554 D-glucose multiple interactions ISO Kynu (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KYNU mRNA CTD PMID:37567420 deoxycholic acid multiple interactions ISO KYNU (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of KYNU mRNA more ... CTD PMID:33819548 diarsenic trioxide increases expression ISO KYNU (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of KYNU mRNA CTD PMID:15761015 dicrotophos decreases expression ISO KYNU (Homo sapiens) 6480464 dicrotophos results in decreased expression of KYNU mRNA CTD PMID:28302478 diethylstilbestrol decreases expression ISO KYNU (Homo sapiens) 6480464 Diethylstilbestrol results in decreased expression of KYNU mRNA CTD PMID:26865669 diquat increases expression ISO KYNU (Homo sapiens) 6480464 Diquat results in increased expression of KYNU mRNA CTD PMID:21172416 diquat increases expression ISO Kynu (Mus musculus) 6480464 Diquat results in increased expression of KYNU mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO KYNU (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of KYNU mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO Kynu (Mus musculus) 6480464 epoxiconazole results in decreased expression of KYNU mRNA CTD PMID:35436446 estrone decreases expression ISO KYNU (Homo sapiens) 6480464 Estrone results in decreased expression of KYNU mRNA CTD PMID:26865669 etoposide affects response to substance ISO KYNU (Homo sapiens) 6480464 KYNU protein affects the susceptibility to Etoposide CTD PMID:16217747 fenvalerate decreases activity ISO Kynu (Mus musculus) 6480464 fenvalerate results in decreased activity of KYNU protein CTD PMID:7175102 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of KYNU mRNA CTD PMID:18035473 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of KYNU mRNA CTD PMID:24136188 and PMID:24793618 folic acid multiple interactions EXP 6480464 [Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Rotenone results in decreased expression of KYNU mRNA] CTD PMID:36553663 fructose multiple interactions ISO Kynu (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KYNU mRNA CTD PMID:37567420 fulvestrant increases expression ISO KYNU (Homo sapiens) 6480464 fulvestrant results in increased expression of KYNU mRNA CTD PMID:26865669 furan decreases expression EXP 6480464 furan results in decreased expression of KYNU mRNA CTD PMID:25539665 and PMID:26194646 gamma-linolenic acid decreases expression ISO KYNU (Homo sapiens) 6480464 gamma-Linolenic Acid results in decreased expression of KYNU mRNA CTD PMID:20664735 genistein decreases expression ISO KYNU (Homo sapiens) 6480464 Genistein results in decreased expression of KYNU mRNA CTD PMID:26865669 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of KYNU mRNA CTD PMID:24136188 glucose multiple interactions ISO Kynu (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of KYNU mRNA CTD PMID:37567420 glycidyl methacrylate decreases expression ISO KYNU (Homo sapiens) 6480464 glycidyl methacrylate results in decreased expression of KYNU protein CTD PMID:36641056 glycochenodeoxycholic acid multiple interactions ISO KYNU (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of KYNU mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO KYNU (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of KYNU mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO KYNU (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of KYNU mRNA more ... CTD PMID:33819548 gold atom increases expression ISO KYNU (Homo sapiens) 6480464 Gold results in increased expression of KYNU mRNA CTD PMID:29705079 gold(0) increases expression ISO KYNU (Homo sapiens) 6480464 Gold results in increased expression of KYNU mRNA CTD PMID:29705079 GW 4064 increases expression ISO Kynu (Mus musculus) 6480464 GW 4064 results in increased expression of KYNU mRNA CTD PMID:26655953 hexestrol decreases expression ISO KYNU (Homo sapiens) 6480464 Hexestrol results in decreased expression of KYNU mRNA CTD PMID:26865669 hydrogen peroxide decreases expression ISO KYNU (Homo sapiens) 6480464 Hydrogen Peroxide results in decreased expression of KYNU mRNA CTD PMID:18951874 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of KYNU mRNA CTD PMID:36868495 ivermectin decreases expression ISO KYNU (Homo sapiens) 6480464 Ivermectin results in decreased expression of KYNU protein CTD PMID:32959892 kynurenine increases expression ISO KYNU (Homo sapiens) 6480464 Kynurenine results in increased expression of KYNU mRNA CTD PMID:32781018 lamivudine multiple interactions ISO KYNU (Homo sapiens) 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of KYNU mRNA CTD PMID:15784690 lipopolysaccharide increases expression ISO KYNU (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of KYNU mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO KYNU (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 menadione affects expression ISO KYNU (Homo sapiens) 6480464 Vitamin K 3 affects the expression of KYNU mRNA CTD PMID:20044591 mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of KYNU mRNA CTD PMID:16507785 mestranol decreases expression ISO KYNU (Homo sapiens) 6480464 Mestranol results in decreased expression of KYNU mRNA CTD PMID:26865669 methamphetamine decreases expression ISO Kynu (Mus musculus) 6480464 Methamphetamine results in decreased expression of KYNU mRNA CTD PMID:26307267 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of KYNU mRNA CTD PMID:16393664 methomyl decreases activity ISO Kynu (Mus musculus) 6480464 Methomyl results in decreased activity of KYNU protein CTD PMID:7175100 methylmercury chloride decreases expression ISO KYNU (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of KYNU mRNA CTD PMID:23179753 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of KYNU gene CTD PMID:33148267 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of KYNU mRNA and [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of KYNU mRNA CTD PMID:18164116 and PMID:28943392 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of KYNU mRNA CTD PMID:25380136 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of KYNU mRNA CTD PMID:24136188 nefazodone multiple interactions ISO KYNU (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of KYNU mRNA CTD PMID:33819548 nickel atom increases expression ISO KYNU (Homo sapiens) 6480464 Nickel results in increased expression of KYNU mRNA CTD PMID:24768652 and PMID:25583101 nickel dichloride increases expression ISO KYNU (Homo sapiens) 6480464 nickel chloride results in increased expression of KYNU mRNA CTD PMID:17312168 nickel sulfate increases expression ISO KYNU (Homo sapiens) 6480464 nickel sulfate results in increased expression of KYNU mRNA CTD PMID:22714537 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of KYNU mRNA CTD PMID:24136188 nitroglycerin decreases expression EXP 6480464 Nitroglycerin results in decreased expression of KYNU protein CTD PMID:28659861 ozone multiple interactions ISO Kynu (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of KYNU mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of KYNU mRNA CTD PMID:34911549 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of KYNU mRNA CTD PMID:27638505 paracetamol affects expression ISO Kynu (Mus musculus) 6480464 Acetaminophen affects the expression of KYNU mRNA CTD PMID:17562736 paracetamol multiple interactions ISO KYNU (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of KYNU mRNA CTD PMID:33819548 paracetamol decreases expression ISO KYNU (Homo sapiens) 6480464 Acetaminophen results in decreased expression of KYNU mRNA CTD PMID:21420995 more ... perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of KYNU mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO Kynu (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of KYNU mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of KYNU mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of KYNU mRNA CTD PMID:19162173 perfluorooctanoic acid decreases expression ISO KYNU (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of KYNU mRNA CTD PMID:23978341 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of KYNU gene CTD PMID:33148267 phenobarbital decreases expression ISO Kynu (Mus musculus) 6480464 Phenobarbital results in decreased expression of KYNU mRNA and Phenobarbital results in decreased expression of KYNU protein CTD PMID:19482888 and PMID:35881160 phenobarbital decreases expression ISO KYNU (Homo sapiens) 6480464 Phenobarbital results in decreased expression of KYNU protein CTD PMID:35881160 phenobarbital multiple interactions ISO Kynu (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of KYNU mRNA] CTD PMID:19482888 phenylmercury acetate increases expression ISO KYNU (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of KYNU mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO KYNU (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KYNU mRNA CTD PMID:27188386 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of KYNU mRNA CTD PMID:33945839 pirinixic acid multiple interactions ISO Kynu (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of KYNU mRNA CTD PMID:19710929 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of KYNU mRNA CTD PMID:19162173 progesterone multiple interactions ISO KYNU (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of KYNU mRNA CTD PMID:20660070 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in decreased expression of KYNU mRNA CTD PMID:25905778 resveratrol multiple interactions ISO KYNU (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of KYNU mRNA CTD PMID:23557933 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of KYNU mRNA CTD PMID:28374803 and PMID:36553663 rotenone multiple interactions EXP 6480464 [Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Rotenone results in decreased expression of KYNU mRNA] CTD PMID:36553663 rotenone decreases expression ISO KYNU (Homo sapiens) 6480464 Rotenone results in decreased expression of KYNU mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO KYNU (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO KYNU (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos increases expression ISO KYNU (Homo sapiens) 6480464 Asbestos and Serpentine results in increased expression of KYNU mRNA CTD PMID:24160326 silicon dioxide affects secretion ISO KYNU (Homo sapiens) 6480464 Silicon Dioxide analog affects the secretion of KYNU protein CTD PMID:25895662 silicon dioxide increases expression ISO KYNU (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of KYNU mRNA CTD PMID:22300531 and PMID:25351596 silver atom increases expression ISO KYNU (Homo sapiens) 6480464 Silver results in increased expression of KYNU mRNA CTD PMID:26014281 silver(0) increases expression ISO KYNU (Homo sapiens) 6480464 Silver results in increased expression of KYNU mRNA CTD PMID:26014281 sodium arsenite increases expression ISO KYNU (Homo sapiens) 6480464 sodium arsenite results in increased expression of KYNU mRNA CTD PMID:22714537 more ... sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of KYNU mRNA CTD PMID:25993096 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in decreased expression of KYNU mRNA CTD PMID:25905778 sulforaphane decreases expression ISO KYNU (Homo sapiens) 6480464 sulforaphane results in decreased expression of KYNU mRNA CTD PMID:26833863 tamoxifen increases expression ISO KYNU (Homo sapiens) 6480464 Tamoxifen results in increased expression of KYNU mRNA CTD PMID:15604281 temozolomide decreases expression ISO KYNU (Homo sapiens) 6480464 Temozolomide results in decreased expression of KYNU mRNA CTD PMID:31758290 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of KYNU mRNA CTD PMID:12734012 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of KYNU mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of KYNU mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO Kynu (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of KYNU mRNA CTD PMID:27339419 and PMID:31919559 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of KYNU mRNA CTD PMID:23411599 and PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of KYNU mRNA CTD PMID:28943392 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of KYNU mRNA CTD PMID:30589522 troglitazone decreases expression ISO Kynu (Mus musculus) 6480464 troglitazone results in decreased expression of KYNU mRNA CTD PMID:28973697 urethane decreases expression ISO KYNU (Homo sapiens) 6480464 Urethane results in decreased expression of KYNU mRNA CTD PMID:28818685 valproic acid affects expression ISO Kynu (Mus musculus) 6480464 Valproic Acid affects the expression of KYNU mRNA CTD PMID:17292431 and PMID:17963808 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of KYNU mRNA CTD PMID:35594946 valproic acid multiple interactions ISO KYNU (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KYNU mRNA CTD PMID:27188386 valproic acid increases expression ISO KYNU (Homo sapiens) 6480464 Valproic Acid results in increased expression of KYNU mRNA CTD PMID:24383497 more ... valproic acid decreases methylation ISO KYNU (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of KYNU gene CTD PMID:29154799 valproic acid decreases expression ISO KYNU (Homo sapiens) 6480464 Valproic Acid results in decreased expression of KYNU mRNA CTD PMID:23179753 vancomycin increases expression ISO Kynu (Mus musculus) 6480464 Vancomycin results in increased expression of KYNU mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of KYNU mRNA CTD PMID:23034163 vincristine increases expression ISO KYNU (Homo sapiens) 6480464 Vincristine results in increased expression of KYNU mRNA CTD PMID:23649840 zidovudine multiple interactions ISO KYNU (Homo sapiens) 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of KYNU mRNA CTD PMID:15784690 zoledronic acid increases expression ISO KYNU (Homo sapiens) 6480464 zoledronic acid results in increased expression of KYNU mRNA CTD PMID:24714768